Yorkshire Lands $3.6M for Prostate Cancer Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK charity Yorkshire Cancer Research (YCR) has given £2.2 million ($3.6 million) to fund research at the University of York that will blend genomics and stem cells studies in an effort to understand the causes of prostate cancer.

The researchers will study the DNA sequences of prostate cancer cells to search for sequences involved in the disease and for molecular properties that allow the cancer to survive, spread, and resist treatment, YCR said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.